ANTX·037326105·US·equity·Healthcare - Biotechnology-Activist
ANTX (AN2 THERAPEUTICS INC) is held by 31 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($7.6M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($3.4M), Woodline Partners LP ($3.4M). Net institutional sentiment: Mixed.
See how ANTX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer